rs1654260
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs1654260(A;A) |
| Make rs1654260(A;G) |
| Make rs1654260(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 20218302 |
| Gene | LOC105372310, LOC105372311 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1654260 |
| dbSNP (classic) | rs1654260 |
| ClinGen | rs1654260 |
| ebi | rs1654260 |
| HLI | rs1654260 |
| Exac | rs1654260 |
| Gnomad | rs1654260 |
| Varsome | rs1654260 |
| LitVar | rs1654260 |
| Map | rs1654260 |
| PheGenI | rs1654260 |
| Biobank | rs1654260 |
| 1000 genomes | rs1654260 |
| hgdp | rs1654260 |
| ensembl | rs1654260 |
| geneview | rs1654260 |
| scholar | rs1654260 |
| rs1654260 | |
| pharmgkb | rs1654260 |
| gwascentral | rs1654260 |
| openSNP | rs1654260 |
| 23andMe | rs1654260 |
| SNPshot | rs1654260 |
| SNPdbe | rs1654260 |
| MSV3d | rs1654260 |
| GWAS Ctlg | rs1654260 |
| GMAF | 0.376 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 23648065 ]
|
| Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) |
| Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
| Risk Allele | A |
| P-val | 8E-6 |
| Odds Ratio | 1.75 [1.365-2.24] |
